Discover 644 paid clinical trials in Milwaukee, Wisconsin. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 644
A Study to Patients With Relapsed/Refractory Follicular Lymphoma Treated With Liso-cel (Lisocabtagene Maraleucel) in the Post Marketing Setting
for
Follicular Lymphoma
Location: Milwaukee WI
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Sex: All
Age: 18+
Code: NCT06794268
Recruiting
Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
for
Relapsing Multiple Sclerosis
Location: Milwaukee WI, Chicago IL, Iowa City IA, Farmington MI,
Sponsor: TG Therapeutics, Inc.
Sex: All
Age: 18 - 65
Code: NCT05877963
Phase3, Recruiting
Post-authorization Safety Study of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Treated With Mogamulizumab
for
Leukemia/Lymphoma, Cutaneous T Cell Lymphoma, ATLL
Location: Milwaukee WI
Sponsor: Kyowa Kirin, Inc.
Sex: All
Age: 18+
Code: NCT04014374
Recruiting
Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
for
Chronic Inflammatory Demyelinating Polyneuropathy
Location: Milwaukee WI, Chicago IL, Detroit MI, Nicholasville KY,
Sponsor: Immunovant Sciences GmbH
Sex: All
Age: 18+
Code: NCT07032662
Phase2, Recruiting
A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
for
Moderate to Severe Plaque Psoriasis, Psoriatic Arthritis,
Location: Milwaukee WI, Durham NC, Chapel Hill NC, Boston MA,
Sponsor: UCB Biopharma SRL
Sex: Female
Age: 18+
Code: NCT06888193
Phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
for
Relapsing Multiple Sclerosis, Multiple Sclerosis
Location: Milwaukee WI, Greenfield WI, Waukesha WI, Evanston IL,
Sponsor: TG Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06433752
Recruiting
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Location: Milwaukee WI, Madison WI, Chicago IL, Green Bay WI,
Sponsor: Sameek Roychowdhury
Sex: All
Age: 18+
Code: NCT06906562
Phase2, Recruiting
A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis
Location: Milwaukee WI, Gurnee IL, Burr Ridge IL, Ann Arbor MI,
Sponsor: Vedanta Biosciences, Inc.
Sex: All
Age: 12+
Code: NCT06237452
Phase3, Recruiting
Use of fenoTRACK Device for Monitoring Changes of Fractional Exhaled Nitric Oxide (FeNO) in Uncontrolled Asthma Subjects and Controlled Asthma Subjects
A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa
for
Myasthenia Gravis
Location: Greenfield WI, Iowa City IA, Detroit MI, O'Fallon IL,
Sponsor: argenx
Sex: All
Age: 18+
Code: NCT06298565
Recruiting
A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)
for
Generalized Myasthenia Gravis
Location: Greenfield WI, Grand Rapids MI, East Lansing MI,
Sponsor: Vor Biopharma
Sex: All
Age: 18+
Code: NCT06456580
Phase3, Recruiting
A Study to Evaluate the Clinical Outcomes of Efgartigimod PH20 SC in Adults With New-onset Generalized Myasthenia Gravis (gMG)
for
New Onset Generalized Myasthenia Gravis (gMG)
Location: Greenfield WI, Detroit MI, O'Fallon IL, Cleveland OH,
Sponsor: argenx
Sex: All
Age: 18+
Code: NCT06909214
Recruiting
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
for
Asthma
Location: Greenfield WI, Westchester IL, Brighton MI, St Louis MO,